JP2015524798A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015524798A5 JP2015524798A5 JP2015521836A JP2015521836A JP2015524798A5 JP 2015524798 A5 JP2015524798 A5 JP 2015524798A5 JP 2015521836 A JP2015521836 A JP 2015521836A JP 2015521836 A JP2015521836 A JP 2015521836A JP 2015524798 A5 JP2015524798 A5 JP 2015524798A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- cyano
- imidazo
- chloro
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CN(**)c(nc1N*)n[n]2c1ncc2N Chemical compound CN(**)c(nc1N*)n[n]2c1ncc2N 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261671179P | 2012-07-13 | 2012-07-13 | |
| US61/671,179 | 2012-07-13 | ||
| US201361790511P | 2013-03-15 | 2013-03-15 | |
| US61/790,511 | 2013-03-15 | ||
| PCT/US2013/050247 WO2014011974A1 (en) | 2012-07-13 | 2013-07-12 | Imidazotriazinecarbonitriles useful as kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015524798A JP2015524798A (ja) | 2015-08-27 |
| JP2015524798A5 true JP2015524798A5 (enExample) | 2016-07-21 |
| JP6228199B2 JP6228199B2 (ja) | 2017-11-08 |
Family
ID=48833089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015521836A Expired - Fee Related JP6228199B2 (ja) | 2012-07-13 | 2013-07-12 | キナーゼ阻害剤として有用であるイミダゾトリアジンカルボニトリル |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US8940736B2 (enExample) |
| EP (1) | EP2872514B1 (enExample) |
| JP (1) | JP6228199B2 (enExample) |
| KR (1) | KR20150059647A (enExample) |
| CN (1) | CN104470925B (enExample) |
| AR (1) | AR092349A1 (enExample) |
| AU (1) | AU2013290054A1 (enExample) |
| BR (1) | BR112015000704A2 (enExample) |
| CA (1) | CA2878852A1 (enExample) |
| CL (1) | CL2015000094A1 (enExample) |
| CO (1) | CO7180199A2 (enExample) |
| EA (1) | EA201590224A1 (enExample) |
| HK (1) | HK1210775A1 (enExample) |
| IL (1) | IL236605A0 (enExample) |
| MX (1) | MX2015000310A (enExample) |
| PE (1) | PE20150332A1 (enExample) |
| PH (1) | PH12015500064A1 (enExample) |
| SG (1) | SG11201500158RA (enExample) |
| TN (1) | TN2015000002A1 (enExample) |
| TW (1) | TW201414737A (enExample) |
| WO (1) | WO2014011974A1 (enExample) |
| ZA (1) | ZA201501009B (enExample) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009008916A2 (en) | 2007-03-22 | 2009-01-15 | The Regents Of The University Of Californina | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| EP2313434A4 (en) | 2008-07-31 | 2013-03-27 | Univ California | ANTIBODIES FOR NEUTRALIZING BOTULINE NEUROTOXINES |
| WO2012047427A2 (en) | 2010-08-31 | 2012-04-12 | The Regents Of The University Of California | Antibodies for botulinum neurotoxins |
| PT2841437T (pt) | 2012-04-26 | 2017-09-28 | Univ Montreal | Derivados de imidazotiadiazol e imidazopirazina como inibidores de recetor 4 ativado por protease (par4) para o tratamento de agregação plaquetária |
| TWI568722B (zh) | 2012-06-15 | 2017-02-01 | 葛蘭馬克製藥公司 | 作爲ｍＰＧＥＳ－１抑制劑之三唑酮化合物 |
| TW201414737A (zh) | 2012-07-13 | 2014-04-16 | 必治妥美雅史谷比公司 | 作爲激酶抑制劑之咪唑并三□甲腈 |
| CA2897200C (en) | 2013-01-14 | 2021-07-06 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors |
| PE20191245A1 (es) | 2013-01-15 | 2019-09-18 | Incyte Holdings Corp | Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de quinasa pim |
| US9227978B2 (en) | 2013-03-15 | 2016-01-05 | Araxes Pharma Llc | Covalent inhibitors of Kras G12C |
| CN105658653A (zh) | 2013-08-23 | 2016-06-08 | 因赛特公司 | 可用作pim激酶抑制剂的呋喃并-和噻吩并-吡啶甲酰胺化合物 |
| JO3805B1 (ar) | 2013-10-10 | 2021-01-31 | Araxes Pharma Llc | مثبطات كراس جي12سي |
| US9822124B2 (en) | 2014-07-14 | 2017-11-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors |
| US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
| DE102014111834A1 (de) * | 2014-08-19 | 2016-02-25 | Illinois Tool Works Inc. | Einfülleinrichtung für einen Betriebsstofftank |
| ES2898765T3 (es) | 2015-04-10 | 2022-03-08 | Araxes Pharma Llc | Compuestos de quinazolina sustituidos y métodos de uso de los mismos |
| WO2016196244A1 (en) | 2015-05-29 | 2016-12-08 | Incyte Corporation | Pyridineamine compounds useful as pim kinase inhibitors |
| AR105967A1 (es) | 2015-09-09 | 2017-11-29 | Incyte Corp | Sales de un inhibidor de pim quinasa |
| WO2017058792A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| EP3356353A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| EP3356347A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| US10975071B2 (en) | 2015-09-28 | 2021-04-13 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| WO2017059251A1 (en) | 2015-10-02 | 2017-04-06 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
| WO2017070137A1 (en) * | 2015-10-20 | 2017-04-27 | Bristol-Myers Squibb Company | Combination of ck2 inhibitors and immune checkpoint modulators for cancer treatment |
| US10550125B2 (en) * | 2015-10-20 | 2020-02-04 | Bristol-Myers Squibb Company | Prodrugs of imidazotriazine compounds as CK2 inhibitors |
| US10414757B2 (en) | 2015-11-16 | 2019-09-17 | Araxes Pharma Llc | 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof |
| EP3474855B1 (en) * | 2016-06-24 | 2022-01-26 | Polaris Pharmaceuticals, Inc. | Ck2 inhibitors, compositions and methods thereof |
| WO2017223414A1 (en) | 2016-06-24 | 2017-12-28 | Incyte Corporation | HETEROCYCLIC COMPOUNDS AS PI3K-γ INHIBITORS |
| EP3573954A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
| US11136308B2 (en) | 2017-01-26 | 2021-10-05 | Araxes Pharma Llc | Substituted quinazoline and quinazolinone compounds and methods of use thereof |
| WO2018140600A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Fused hetero-hetero bicyclic compounds and methods of use thereof |
| EP3573971A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer |
| WO2018140599A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| KR20200010306A (ko) | 2017-05-25 | 2020-01-30 | 아락세스 파마 엘엘씨 | Kras의 공유적 억제제 |
| WO2018218069A1 (en) | 2017-05-25 | 2018-11-29 | Araxes Pharma Llc | Quinazoline derivatives as modulators of mutant kras, hras or nras |
| TW202517628A (zh) * | 2017-09-11 | 2025-05-01 | 美商克魯松藥物公司 | Shp2之八氫環戊烷并[c]吡咯別構抑制劑 |
| WO2019113487A1 (en) | 2017-12-08 | 2019-06-13 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
| CA3107168A1 (en) | 2018-08-01 | 2020-02-06 | Araxes Pharma Llc | Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer |
| KR20210083286A (ko) * | 2018-10-24 | 2021-07-06 | 아락세스 파마 엘엘씨 | 종양 전이를 억제하기 위한 g12c 돌연변이 kras 단백질의 억제제로서 2-(2-아크릴로일-2,6-디아자스피로[3.4]옥탄-6-일)-6-(1h-인다졸-4-일)-벤조니트릴 유도체 및 관련 화합물 |
| IL285315B2 (en) * | 2019-02-07 | 2025-12-01 | Beigene Ltd | Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as tlr7 agonist |
| AR119494A1 (es) * | 2019-07-29 | 2021-12-22 | Servier Lab | DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS |
| KR102800341B1 (ko) | 2019-10-02 | 2025-04-23 | 톨레모 테라퓨틱스 아게 | 헤테로사이클릭 유도체, 약학 조성물 및 암의 치료 또는 개선에서 그들의 용도 |
| US12472179B2 (en) | 2020-06-25 | 2025-11-18 | Tolremo Therapeutics Ag | Combination of a CBP/p300 bromodomain inhibitor and a KRAS inhibitor for the treatment of cancer |
| CN120769855A (zh) * | 2022-11-03 | 2025-10-10 | 生物衔接医疗公司 | 4-氨基吡咯并[2,1-f][1,2,4]三嗪及其制备和用途 |
| WO2024220399A1 (en) * | 2023-04-17 | 2024-10-24 | Bristol-Myers Squibb Company | Pyrazolotriazinecarbonitriles useful as kinase inhibitors |
| WO2025074096A1 (en) * | 2023-10-02 | 2025-04-10 | Turbine Simulated Cell Technologies Ltd | P97 (vcp) atpase inhibitors |
| WO2025193691A1 (en) * | 2024-03-12 | 2025-09-18 | Casma Therapeutics, Inc. | Bicyclic heteroaromatic compounds as trpml modulators |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4327027A1 (de) | 1993-02-15 | 1994-08-18 | Bayer Ag | Imidazoazine |
| TWI312347B (en) | 2001-02-08 | 2009-07-21 | Eisai R&D Man Co Ltd | Bicyclic nitrogen-containing condensed ring compounds |
| MY145634A (en) | 2003-12-29 | 2012-03-15 | Bristol Myers Squibb Co | Pyrrolotriazine compounds as kinase inhibitors |
| WO2006065788A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Novel muscarinic acetylcholine receptor antagonists |
| WO2006065755A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists |
| US20070078136A1 (en) * | 2005-09-22 | 2007-04-05 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| CN101312977B (zh) * | 2005-09-22 | 2012-06-13 | 布里斯托尔-迈尔斯.斯奎布公司 | 用作激酶调节剂的稠合杂环化合物 |
| US7723336B2 (en) | 2005-09-22 | 2010-05-25 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| WO2008057402A2 (en) | 2006-11-02 | 2008-05-15 | Cytovia, Inc. | N-aryl-isoxazolopyrimidin-4-amines and related compounds as activators of caspases and inducers of apoptosis and the use thereof |
| WO2008116064A2 (en) | 2007-03-21 | 2008-09-25 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases |
| CN102164604A (zh) | 2008-07-24 | 2011-08-24 | 百时美施贵宝公司 | 用作激酶调节剂的稠合杂环化合物 |
| TWI491610B (zh) * | 2008-10-09 | 2015-07-11 | 必治妥美雅史谷比公司 | 作為激酶抑制劑之咪唑并嗒腈 |
| WO2010068810A2 (en) * | 2008-12-10 | 2010-06-17 | Cgi Pharmaceuticals, Inc. | Certain substituted amides, method of making, and method of use thereof |
| CA2773854A1 (en) * | 2009-09-11 | 2011-03-17 | Cylene Pharmaceuticals Inc. | Pharmaceutically useful heterocycle-substituted lactams |
| KR101851130B1 (ko) * | 2009-12-04 | 2018-04-23 | 센화 바이오사이언시즈 인코포레이티드 | Ｃｋ2 억제제로서 피라졸로피리미딘 및 관련된 헤테로사이클 |
| EP2526102B1 (en) | 2010-01-22 | 2017-03-08 | Fundación Centro Nacional de Investigaciones Oncológicas Carlos III | Inhibitors of PI3 kinase |
| WO2011141713A1 (en) | 2010-05-13 | 2011-11-17 | Centro Nacional De Investigaciones Oncologicas (Cnio) | New bicyclic compounds as pi3-k and mtor inhibitors |
| TW201414737A (zh) | 2012-07-13 | 2014-04-16 | 必治妥美雅史谷比公司 | 作爲激酶抑制劑之咪唑并三□甲腈 |
-
2013
- 2013-07-11 TW TW102125007A patent/TW201414737A/zh unknown
- 2013-07-12 US US13/940,619 patent/US8940736B2/en active Active
- 2013-07-12 EA EA201590224A patent/EA201590224A1/ru unknown
- 2013-07-12 SG SG11201500158RA patent/SG11201500158RA/en unknown
- 2013-07-12 US US14/414,152 patent/US9273057B2/en active Active
- 2013-07-12 HK HK15111498.7A patent/HK1210775A1/xx unknown
- 2013-07-12 AU AU2013290054A patent/AU2013290054A1/en not_active Abandoned
- 2013-07-12 PE PE2015000038A patent/PE20150332A1/es not_active Application Discontinuation
- 2013-07-12 CA CA2878852A patent/CA2878852A1/en not_active Abandoned
- 2013-07-12 BR BR112015000704A patent/BR112015000704A2/pt not_active IP Right Cessation
- 2013-07-12 EP EP13739922.6A patent/EP2872514B1/en not_active Not-in-force
- 2013-07-12 WO PCT/US2013/050247 patent/WO2014011974A1/en not_active Ceased
- 2013-07-12 MX MX2015000310A patent/MX2015000310A/es unknown
- 2013-07-12 AR ARP130102495A patent/AR092349A1/es unknown
- 2013-07-12 KR KR1020157003512A patent/KR20150059647A/ko not_active Withdrawn
- 2013-07-12 CN CN201380037444.6A patent/CN104470925B/zh not_active Expired - Fee Related
- 2013-07-12 JP JP2015521836A patent/JP6228199B2/ja not_active Expired - Fee Related
-
2014
- 2014-11-04 US US14/532,218 patent/US9556178B2/en active Active
-
2015
- 2015-01-05 TN TNP2015000002A patent/TN2015000002A1/fr unknown
- 2015-01-06 IL IL236605A patent/IL236605A0/en unknown
- 2015-01-12 PH PH12015500064A patent/PH12015500064A1/en unknown
- 2015-01-13 CL CL2015000094A patent/CL2015000094A1/es unknown
- 2015-01-26 CO CO15014912A patent/CO7180199A2/es unknown
- 2015-02-12 ZA ZA2015/01009A patent/ZA201501009B/en unknown
- 2015-12-21 US US14/976,476 patent/US20160108050A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015524798A5 (enExample) | ||
| US11197858B2 (en) | Substituted amines for treating cardiac diseases | |
| US11129832B2 (en) | Biheteroaryl compounds and uses thereof | |
| JP6228199B2 (ja) | キナーゼ阻害剤として有用であるイミダゾトリアジンカルボニトリル | |
| CN116323623B (zh) | 作为SOS1抑制剂的吡啶并[2,3-d]嘧啶-4-胺 | |
| KR101843600B1 (ko) | 트리아진-옥사디아졸 | |
| ES2727376T3 (es) | Derivados de aminotriazina útiles como compuestos inhibidores de quinasa de unión TANK | |
| CN102596913B (zh) | 大麻素受体调节剂 | |
| AU2019262927A1 (en) | Pyridazinones as PARP7 inhibitors | |
| RU2018105684A (ru) | Замещенные трициклические соединения и способ применения | |
| JP2018530557A5 (enExample) | ||
| TW201722948A (zh) | Ｎ－磺醯化吡唑并﹝３，４－ｂ﹞吡啶－６－甲醯胺及其使用方法 | |
| EP2852584A1 (en) | Substituted dipyridylamines and uses thereof | |
| JP2018522929A5 (enExample) | ||
| JP2018530557A (ja) | 置換ピラゾロ［３，４−ｂ］ピリジン−６−カルボン酸およびこの使用 | |
| HRP20210935T1 (hr) | Spojevi 5-kloro-2-difluorometoksifenil pirazolopirimidina koji predstavljaju inhibitore jak | |
| US20160159773A1 (en) | Heterocyclic compound | |
| US20180155285A1 (en) | 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones | |
| EP3317279B1 (en) | Triaza-spirodecanones as ddr1 inhibitors | |
| JP2017531672A5 (enExample) | ||
| JP2024009891A (ja) | Ｔ型カルシウムチャネル阻害剤 | |
| AU2021242143B2 (en) | Aminopyrimidine derivatives and their use as Aryl hydrocarbon receptor modulators | |
| EP3950059A1 (en) | Use of t-type calcium channel blocker for treating pruritus |